Calcification of vascular smooth muscle cells and imaging of aortic calcification and inflammation

Journal of Visualized Experiments

Volumn 2016, Issue 111, 2016, Pages

  O'rourke, Caitlin ^a   Shelton, Georgia ^a   Hutcheson, Joshua D ^b,c   Burke, Megan F ^a   Martyn, Trejeeve ^a   Thayer, Timothy E ^a   Shakartzi, Hannah R ^a   Buswell, Mary D ^a   Tainsh, Robert E ^a   Yu, Binglan ^a,c   Bagchi, Aranya ^a,c   Rhee, David K ^a,c   Wu, Connie ^a,c   Derwall, Matthias ^d   Buys, Emmanuel S ^a,c   Yu, Paul B ^b,c   Bloch, Kenneth D ^a,c   Aikawa, Elena ^b,c   Bloch, Donald B ^a,d   Malhotra, Rajeev ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Atherosclerosis; Issue 111; Macrophage; Matrix gla protein; Medicine; Near infrared fluorescent imaging; Smooth muscle cell; Vascular calcification; Vascular inflammation

Indexed keywords

ANIMAL; AORTIC DISEASES; ATHEROSCLEROSIS; CALCINOSIS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; HUMAN; INFLAMMATION; METABOLISM; MOUSE; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTIC DISEASES; ATHEROSCLEROSIS; CALCINOSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFLAMMATION; MICE; MUSCLE, SMOOTH, VASCULAR;

EID: 84971505191     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/54017     Document Type: Article

References (71)

1. Go, A. S. et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 129 (3), e28-e292 (2014).
2. Wilson, P. W. et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 103 (11), 1529-1534 (2001).
3. Budoff, M. J. et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 114 (16), 1761-1791 (2006).
4. Greenland, P., LaBree, L., Azen, S. P., Doherty, T. M., & Detrano, R. C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. Jama. 291 (2) (2004).
5. Otsuka, F., Sakakura, K., Yahagi, K., Joner, M., & Virmani, R. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol. 34 (4), 724-736 (2014).
6. Virmani, R., Burke, A. P., Farb, A., & Kolodgie, F. D. Pathology of the vulnerable plaque. J Am Coll Cardiol. 47 (8 Suppl), C13-18 (2006).
7. Amann, K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 3 (6), 1599-1605 (2008).
8. Aikawa, E. et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation. 119 (13), 1785-1794 (2009).
9. Aikawa, E. et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 116 (24), 2841-2850 (2007).
10. Qiao, J. H. et al. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb. 14 (9), 1480-1497 (1994).
11. Derwall, M. et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 32 (3), 613-622 (2012).
12. Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386 (6620), 78-81 (1997).
13. Shobeiri, N., Adams, M. A., & Holden, R. M. Vascular calcification in animal models of CKD: A review. Am J Nephrol. 31 (6), 471-481 (2010).
14. Keutel, J., Jorgensen, G., & Gabriel, P. [A new autosomal-recessive hereditary syndrome. Multiple peripheral pulmonary stenosis, brachytelephalangia, inner-ear deafness, ossification or calcification of cartilages]. Dtsch Med Wochenschr. 96 (43), 1676-1681 (1971).
15. Munroe, P. B. et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 21 (1), 142-144 (1999).
16. Cormode, E. J., Dawson, M., & Lowry, R. B. Keutel syndrome: clinical report and literature review. Am J Med Genet. 24 (2), 289-294 (1986).
17. Fryns, J. P., van Fleteren, A., Mattelaer, P., & van den Berghe, H. Calcification of cartilages, brachytelephalangy and peripheral pulmonary stenosis. Confirmation of the Keutel syndrome. Eur J Pediatr. 142 (3), 201-203 (1984).
18. Ozdemir, N. et al. Tracheobronchial calcification associated with Keutel syndrome. Turk J Pediatr. 48 (4), 357-361 (2006).
19. Cranenburg, E. C. et al. Circulating matrix gamma-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome. J Thromb Haemost. 9 (6), 1225-1235 (2011).
20. Meier, M., Weng, L. P., Alexandrakis, E., Ruschoff, J., & Goeckenjan, G. Tracheobronchial stenosis in Keutel syndrome. Eur Respir J. 17 (3), 566-569 (2001).
21. Wang, Y. et al. Common genetic variants of MGP are associated with calcification on the arterial wall but not with calcification present in the atherosclerotic plaques. Circ Cardiovasc Genet. 6 (3), 271-278 (2013).
22. Cassidy-Bushrow, A. E. et al. Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progression. Arterioscler Thromb Vasc Biol. 33 (3), 645-651 (2013).
23. Crosier, M. D. et al. Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol (Tokyo). 55 (1), 59-65 (2009).
24. Liu, Y. P. et al. Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population. Hypertension. 65 (2), 463-470 (2015).
25. Malhotra, R. et al. Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency. PLoS One. 10 (1), e0117098 (2015).
26. Demer, L. L., & Tintut, Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol. 34 (4), 715-723 (2014).
27. Rusanescu, G., Weissleder, R., & Aikawa, E. Notch signaling in cardiovascular disease and calcification. Curr Cardiol Rev. 4 (3), 148-156 (2008).
28. Leopold, J. A. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 25 (4), 267-274 (2015).
29. Bostrom, K. I., Rajamannan, N. M., & Towler, D. A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res. 109 (5), 564-577 (2011).
30. Hruska, K. A., Mathew, S., & Saab, G. Bone morphogenetic proteins in vascular calcification. Circ Res. 97 (2), 105-114 (2005).
31. Yao, Y. et al. Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res. 107 (4), 485-494 (2010).
32. Bostrom, K. et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 91 (4), 1800-1809 (1993).
33. Bragdon, B. et al. Bone morphogenetic proteins: a critical review. Cell Signal. 23 (4), 609-620 (2011).
34. Cai, J., Pardali, E., Sanchez-Duffhues, G., & ten Dijke, P. BMP signaling in vascular diseases. FEBS Lett. 586 (14), 1993-2002 (2012).
35. Lee, K. S. et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 20 (23), 8783-8792 (2000).
36. Matsubara, T. et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem. 283 (43), 29119-29125 (2008).
37. Li, X., Yang, H. Y., & Giachelli, C. M. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 199 (2), 271-277 (2008).
38. Nakagawa, Y. et al. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler. Thromb. Vasc. Biol. 30 (10), 1908-1915 (2010).
39. Cuny, G. D. et al. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett. 18 (15), 4388-4392 (2008).
40. Yu, P. B. et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med. 14 (12), 1363-1369 (2008).
41. Schurgers, L. J., Uitto, J., & Reutelingsperger, C. P. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 19 (4), 217-226 (2013).
42. Speer, M. Y. et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 104 (6), 733-741 (2009).
43. Speer, M. Y., Li, X., Hiremath, P. G., & Giachelli, C. M. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem. 110 (4), 935-947 (2010).
44. Steitz, S. A. et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 89 (12), 1147-1154 (2001).
45. Inoue, T., Plieth, D., Venkov, C. D., Xu, C., & Neilson, E. G. Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int. 67 (6), 2488-2493 (2005).
46. Zaheer, A. et al. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol. 19 (12), 1148-1154 (2001).
47. Aikawa, E. et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 115 (3), 377-386 (2007).
48. Lee, K. J., Czech, L., Waypa, G. B., & Farrow, K. N. Isolation of pulmonary artery smooth muscle cells from neonatal mice. J Vis Exp. (80), e50889 (2013).
49. Tang, Y., Herr, G., Johnson, W., Resnik, E., & Aho, J. Induction and analysis of epithelial to mesenchymal transition. J Vis Exp. (78) (2013).
50. Puchtler, H., & Meloan, S. N. Demonstration of phosphates in calcium deposits: a modification of von Kossa's reaction. Histochemistry. 56 (3-4), 177-185 (1978).
51. Krahn, K. N., Bouten, C. V., van Tuijl, S., van Zandvoort, M. A., & Merkx, M. Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. Anal Biochem. 350 (2), 177-185 (2006).
52. Johnson, R. C., Leopold, J. A., & Loscalzo, J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 99 (10), 1044-1059 (2006).
53. Vengrenyuk, Y. et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci U S A. 103 (40), 14678-14683 (2006).
54. Maldonado, N. et al. A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am J Physiol Heart Circ Physiol. 303 (5), H619-628 (2012).
55. Toussaint, N. D., & Kerr, P. G. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Nephrology (Carlton). 12 (5), 500-509 (2007).
56. Vines, D. C., Green, D. E., Kudo, G., & Keller, H. Evaluation of mouse tail-vein injections both qualitatively and quantitatively on small-animal PET tail scans. J Nucl Med Technol. 39 (4), 264-270 (2011).
57. Smith, J. G. et al. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. Jama. 312 (17) (2014).
58. Thanassoulis, G. et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 368 (6), 503-512 (2013).
59. Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 90 (2), 844-853 (1994).
60. New, S. E., & Aikawa, E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res. 108 (11), 1381-1391 (2011).
61. Jaffer, F. A., Libby, P., & Weissleder, R. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol. 29 (7), 1017-1024 (2009).
62. Stern, P. H. Antiresorptive agents and osteoclast apoptosis. J Cell Biochem. 101 (5), 1087-1096 (2007).
63. Ray, J. L., Leach, R., Herbert, J. M., & Benson, M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23 (4), 185-188 (2001).
64. Chamley-Campbell, J., Campbell, G. R., & Ross, R. The smooth muscle cell in culture. Physiol Rev. 59 (1), 1-61 (1979).
65. Trion, A., Schutte-Bart, C., Bax, W. H., Jukema, J. W., & van der Laarse, A. Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination. Mol Cell Biochem. 308 (1-2), 25-33 (2008).
66. Mori, K., Shioi, A., Jono, S., Nishizawa, Y., & Morii, H. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 19 (9), 2112-2118 (1999).
67. Thyberg, J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol. 169 183-265 (1996).
68. Dinardo, C. L. et al. Vascular smooth muscle cells exhibit a progressive loss of rigidity with serial culture passaging. Biorheology. 49 (5-6), 365-373 (2012).
69. Metz, R. P., Patterson, J. L., & Wilson, E. Vascular smooth muscle cells: isolation, culture, and characterization. Methods Mol Biol. 843 169-176 (2012).
70. Proudfoot, D., & Shanahan, C. Human vascular smooth muscle cell culture. Methods Mol Biol. 806 251-263 (2012).
71. Hruska, K. A. Vascular smooth muscle cells in the pathogenesis of vascular calcification. Circ Res. 104 (6), 710-711 (2009).